齐鲁晚报·齐鲁壹点 连宁燕 9月25日上午，威海市政府新闻办举行新闻发布会。威海市委常委、常务副市长李建，威海市发展改革 委党组书记、主任张宗浩，威海市科技局副局长、三级调研员姜新，威海市商务局党组成员、副局长陈 金，威海市文化和旅游局党组成员、副局长刘爱春，介绍全市服务业高质量发展有关情况。 近年来，威海市上下深入贯彻落实中央、省、市关于加快服务业高质量发展部署要求，牢固树立大抓经 济鲜明导向，强化政策驱动、产业强基、消费引领，推动传统服务业转型升级、现代服务业做大做强， 各项工作取得明显成效。 坚持政策驱动构建良好发展环境 通过规划引领和政策引导"双轮驱动"，推动服务业运行稳中向好。 一方面，强化顶层设计。用中长期规划引领指导经济社会发展是我们党治国理政的重要方式，近年来， 共编制市级服务业专项规划16个，涵盖科技创新、文旅发展、养老服务等多个领域，各级紧扣规划的时 间表、路线图，持续推动服务业重点行业平稳发展。尤其今年以来，全市服务业发展稳健向好、进中提 质，上半年实现服务业增加值1091.54亿元，占GDP比重达到55.7%；增长7.4%，居全省第1位，分别高 于全国、全省1.9个和1.6个百分点。 ...

Core Viewpoint - The company's stock price has declined significantly, reflecting challenges in its core business operations and ongoing legal issues [1] Financial Performance - The company reported a revenue of 151 million yuan for the first half of 2025, a year-on-year decrease of 5.77% [1] - The net profit attributable to shareholders was 2.25 million yuan, down 30.54% compared to the previous year [1] Business Operations - The health supplement raw material business has experienced a decline due to intensified industry competition [1] - The medical and nursing business faced interruptions in operational income due to management agreement disputes, with related litigation currently in the second instance [1] Market Activity - The stock price was reported at 8.33 yuan, down 6.19% from the previous trading day, with a trading volume of 172 million yuan [1] - Institutional investors held a total of 58.7% of the shares as of July 30, a decrease of 0.57 percentage points from the previous quarter [1] Capital Flow - On July 31, the net outflow of main funds was 8.32 million yuan, accounting for 0.13% of the circulating market value [2]

Core Viewpoint - The company, Jiaoda Onlly (交大昂立), reported a decline in both revenue and net profit for the first half of 2025, alongside being under investigation by the China Securities Regulatory Commission (CSRC) for information disclosure violations [1][2]. Financial Performance - The company achieved a revenue of 151 million yuan, a year-on-year decrease of 5.77% [1]. - The net profit attributable to shareholders was 2.25 million yuan, down 30.54% year-on-year [1]. - The net profit after deducting non-recurring gains and losses was -2.13 million yuan, indicating an increase in losses compared to the previous year [1]. Business Segments - The main business areas of the company include the research, production, and sales of health products, as well as the operation and management of elderly medical care institutions [1]. - In the 2024 annual report, the revenue contributions from health products, real estate, and medical care businesses were 48.45%, 5.01%, and 45.33%, respectively [1]. Challenges and Legal Issues - The health product segment faced a slight decline due to intensified competition in the domestic probiotic industry and changes in tariff policies in North America [2]. - The medical care segment has encountered issues as various non-profit institutions unilaterally terminated management consulting agreements and refused to pay management fees, leading the company to file lawsuits [2]. - The company received a notice from the CSRC regarding an investigation for suspected violations of information disclosure laws [2].

Core Viewpoint - Shaanxi Jinye (000812) anticipates a significant decline in net profit for the first half of 2025, primarily due to pressures in the tobacco packaging industry and increased operational costs in its education sector [1][4]. Financial Performance - The company expects a net profit attributable to shareholders of between 22.1 million and 28.3 million yuan for the first half of 2025, representing a year-on-year decrease of 55% to 65% [1]. - For 2024, the company achieved a total asset scale exceeding 5 billion yuan and a net asset scale surpassing 1.8 billion yuan, both reaching historical highs [2]. - The net cash flow from operating activities for 2024 increased by 19.39% year-on-year, indicating improved cash flow stability through better management of accounts receivable and optimized fund usage [2]. Business Segments - In 2024, the tobacco packaging business accounted for 58.58% of total revenue, with a gross margin increase of 0.41 percentage points to 25.3%, reflecting effective raw material procurement and process optimization [3]. - The education business saw a revenue growth of 9.9% year-on-year, contributing significantly to net profit, with Mingde College enhancing its faculty investment for future development [3]. - The company maintains a three-pronged strategy focusing on consolidating tobacco packaging, developing education, and nurturing healthcare, emphasizing a commitment to core business operations [3]. Long-term Outlook - Despite short-term performance challenges, the company's strategic investments in tobacco packaging, education, and healthcare indicate potential for long-term growth [4]. - Cost optimization, business structure adjustments, and the cultivation of emerging projects are expected to gradually mitigate the risks associated with declining performance [4].

Group 1 - The company will hold its 2024 Annual General Meeting on May 20, 2025, at 14:30, with both on-site and online voting options available [1][2] - The meeting agenda includes the reading of the meeting notice, discussion of proposals, shareholder speeches, and voting procedures [2][3] - There are 9 proposals to be voted on, requiring more than half of the voting rights held by attending shareholders for approval [4] Group 2 - The company reported a net profit of 30.48 million yuan for 2024, marking a turnaround from previous losses, with total assets of 758.88 million yuan and net assets of 325.71 million yuan [5] - The board of directors has organized two shareholder meetings during the reporting period, addressing various reports and proposals [6][7] - The board held 9 meetings, discussing topics such as executive compensation and the election of board members [8][9] Group 3 - The supervisory board held 6 meetings, reviewing the company's financial reports and ensuring compliance with legal regulations [26][31] - The supervisory board confirmed that the company operates in accordance with laws and regulations, with no violations reported [32] - The company has established a sound internal control system, with audits confirming compliance and effectiveness [35] Group 4 - The company plans to distribute a cash dividend of 0.118 yuan per share for the 2024 fiscal year, totaling approximately 9.14 million yuan, which is 30% of the net profit [40] - The company has outlined its expected related party transactions for 2024 and 2025, with a total estimated amount of 74.5 million yuan for various services [42][43] - The company has implemented measures to manage insider information and ensure compliance with disclosure regulations [22][36]